SORGYVA - HYALURONIC ACID 0.2% WITH AMINOACIDS PRESERVATIVE FREE (OPHTHALMOLOGY – DRY EYE) - EYE DROP

SORGYVA - HYALURONIC ACID 0.2% WITH AMINOACIDS PRESERVATIVE FREE (OPHTHALMOLOGY – DRY EYE) - EYE DROP
Product Description

Aminoacids stabilize sodium hyaluronate viscosity during blinking, ensuring its distribution and adhesion onto the corneal surface and favouring its hydrating and protective effect. Synergy between Aminoacids and Sodium Hyaluronate leads to tear film stability and corneal reparation. Preservative free, Phosphate free.
- Presentation: 10 ml Novelia bottle. 
- Class: Medical Device IIa
- CE Mark expiry date: 2024

-        3 Scientific publications available

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
Specifications
  • Selling Points
    Product Features
  • Supplied from
    Italy

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

More Products from NTC S.r.l. (29)

NTC S.r.l. resources (1)

  • Brochure Therapeutical areas - brochure

    Advanced scientific research and technology drive our efforts to innovate care practices.
    Our range of products builds from our historical vocation for innovation aimed at improving the experience of patients and healthcare practices.
    An innovation aimed at discovering specific therapeutic gestures: simple and intuitive,  sustainable, and technically advanced for empowering the patient.
    Our research aims to put pioneering new products within the reach of everyone and to optimize the
    performance of our products by analyzing the daily needs and habits of people undergoing treatment.
    We research, develop and produce innovative drugs, medical devices and food supplements.
    We market our products worldwide through licensing, distribution, marketing, and commercial deals with partner companies.
    Our core therapeutic areas are: Ophthalmology, Gastro-Metabolism, Pediatrics and Gynacology.